Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer Clinical Trial

Official title:
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

Status Recruiting

Clinical Trial Summary

Clinical Trial Description

Patients with advanced primary liver cancer will be enrolled in the trial , then the patients will be treated with the Elemene Injection/Elemene Oral Emulusion in Combination with the best supportive treatment .The purpose of the study is to evaluate the effect and safety of the Elemene Injection/Elemene Oral Emulusion in Combination with the best supportive treatment in the treatment of advanced primary liver cancer ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03167775
Study type	Interventional
Source	BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
Contact	Shukui Qin
Phone	025-80864541
Email	qinsk@csco.org.cn
Status	Recruiting
Phase	N/A
Start date	November 28, 2016
Completion date	November 27, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03166553` - Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer	N/A
Not yet recruiting	`NCT05411757` - IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer	Early Phase 1
Completed	`NCT03092895` - A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC	Phase 2